What is the brand name of isoproterenol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Isoproterenol Brand Names

Isoproterenol is marketed under several brand names, most commonly as Isuprel in the United States, though it is frequently dispensed as generic isoproterenol hydrochloride injection. 1

Available Formulations

  • The FDA-approved formulation is isoproterenol hydrochloride injection, supplied as 0.2 mg per mL in single-dose vials for intravenous administration. 1

  • The drug is manufactured as a sterile, nonpyrogenic, preservative-free solution that must be protected from light and stored in opaque containers until use. 1

  • Isoproterenol hydrochloride is chemically described as 3,4-Dihydroxy-α-[(isopropylamino)methyl] benzyl alcohol hydrochloride, a racemic compound with molecular weight 247.72. 1

International Nomenclature

  • In many countries outside the United States, isoproterenol is referred to by its International Nonproprietary Name (INN): isoprenaline. 2, 3

  • The terms "isoproterenol" (USAN) and "isoprenaline" (INN) refer to the identical drug and are used interchangeably in medical literature and clinical practice. 2

Clinical Context

  • Isoproterenol is a non-selective β-adrenergic agonist used primarily as a second-line agent for symptomatic bradycardia after atropine failure, and in electrophysiology laboratories for diagnostic purposes at 1-20 mcg/min intravenously. 2

  • The extremely short elimination half-life of 2-5 minutes necessitates continuous infusion rather than bolus administration, which explains why it is only available as an injectable formulation. 4

References

Guideline

Isoproterenol Use in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Mechanism and Clinical Implications of Isoproterenol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Isoproterenol Pharmacokinetics and Clinical Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.